|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Canasa (mesalamine) Suppositories, Axcan Scandipharm NDA 21-252/S2 10/14/03 10/17/03 Canasa (mesalamine) Suppositories, Axcan Scandipharm NDA 21-252 Pentasa (Mesalamine) Capsules Roberts NDA 20-049/S006 MESALAMINE Capsule, Extended Release; 250MG PENTASA SHIRE 019618 MESALAMINE Enema; Rectal 4GM/60ML ROWASA SOLVAY 021252 MESALAMINE Suppository; Rectal 500MG CANASA AXCAN SCANDIPHARM 019651 MESALAMINE Tablet, Delayed Release; 400MG ASACOL PROCTER AND GAMBLE Pentasa (meslamine) Controlled Release Capsules, Shire Pharmaceutical, Control Supplement | Mesalamine Rectal Suspension, Clay-Park Labs, Approval | CANASA (mesalamine) Suppository, Axcan Scandipharm, Labeling Revision | Canasa (Mesalamine, USP) Rectal Suppositories, Axcan Scandipharm, New Dosage Regimen | ROWASA (mesalamine) Rectal Suspension Enema, Solvay Pharma, Labeling Revision | Canasa (mesalamine) Suppository, Axcan Scandipharm, Labeling Revision | Pentasa (mesalamine) Controlled-Release Capsules, Shire Dev., Labeling Revision | Lialda (mesalamine) Delayed Release Tablets, Shire Development, Approval
|